Numerous healthcare technology companies are jostling to get products leveraging AI in front of healthcare providers on the front lines of the battle against COVID-19.

Amazon Web Services is corralling the expertise of more than 30 research institutions, businesses and startups to help combat COVID-19. The cloud giant has allotted $20 million for the work.  

Researchers from Spain used nearly 1,000 pelvic and lower limb MRIs, displaying various forms of the disease, to create their model.

Mayo Clinic researchers have found that primary care providers welcome the concept of AI-based clinical decision support (CDS) while preferring not to use the technology—at least as configured for their tryout adoption—in day-to-day practice.

Tampa General Hospital in Florida has admitted three patients with COVID-19. Halfway around the world, Sheba Medical Center in Israel has seen 40. Both expect exponential increases—and both are using new AI applications to respond.  

“With AI, cancer imaging can move from an inherently subjective tool to a quantitative and objective asset for precision medicine approaches," Columbia University Irving Medical Center radiologists wrote Friday.

The college shared high-level principles in its comments submitted to the White House Office of Management and Budget, emphasizing validation, transparency and safety.

The COVID-19 Detection Neural Network—or COVNet for short—scored high marks in sensitivity and specificity, experts reported in Radiology.